Geographic · Carryforward Amount

Other countries — Carryforward Amount

Edwards Lifesciences Other countries — Carryforward Amount increased by 11.1% to $575.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $517.80M to $575.40M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

An increase suggests higher potential for future tax shields, while a decrease may indicate utilization of these assets or expiration.

Detailed definition

Represents the total gross amount of tax loss or credit carryforwards available for use in international jurisdictions o...

Peer comparison

Standard deferred tax asset disclosure found in the tax footnote of most multinational corporations.

Metric ID: ew_segment_other_countries_carryforward_amount

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$353.30M$390.50M$416.50M$517.80M$575.40M
QoQ Change+10.5%+6.7%+24.3%+11.1%
YoY Change+10.5%+6.7%+24.3%+11.1%
Range$353.30M$575.40M
CAGR+62.9%
Avg YoY Growth+13.2%
Median YoY Growth+10.8%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Edwards Lifesciences's other countries — carryforward amount?
Edwards Lifesciences (EW) reported other countries — carryforward amount of $575.40M in Q4 2025.
How has Edwards Lifesciences's other countries — carryforward amount changed year-over-year?
Edwards Lifesciences's other countries — carryforward amount increased by 11.1% year-over-year, from $517.80M to $575.40M.
What does other countries — carryforward amount mean?
The total value of tax losses or credits available to reduce future tax payments in international markets.